Resistance and support
189.00
![](https://www.icicidirect.com/Content/images/graph17.png)
Financials( ₹ in Cr) | Sudarshan Pharma Industries Ltd | Adani Enterprises Ltd | Aegis Logistics Ltd | Cello World Ltd | Redington Ltd |
---|---|---|---|---|---|
Price | 187.00 | 3,108.80 | 749.75 | 879.50 | 202.72 |
% Change | 0.73 | 2.26 | -0.08 | -1.01 | 1.34 |
Mcap ₹ Cr | 450.03 | 354,403.51 | 26,316.23 | 19,426.84 | 15,848.12 |
Revenue TTM ₹ Cr | 461.33 | 96,420.98 | 7,045.92 | 2,000.26 | 89,345.71 |
Net Profit TTM ₹ Cr | 7.04 | 3,294.63 | 672.20 | 356.18 | 1,238.61 |
PE TTM | 39.29 | 83.01 | 44.98 | 57.87 | 13.04 |
1 Year Return | 161.17 | 26.58 | 105.66 | 11.09 | 35.60 |
ROCE | 15.24 | 8.94 | 16.09 | 35.64 | 19.80 |
ROE | 10.77 | 9.14 | 18.10 | 47.95 | 17.11 |
Equity Capital: 100.98 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 37,516.17 | -14,555.25 |
LAST 3M | 90,902.40 | 37,557.41 |
LAST 6M | 198,345.87 | 43,710.77 |
LAST 12M | 329,168.77 | 54,053.10 |
Date | Action Type | Ratio |
---|---|---|
Aug 25, 2023 | Dividend | 3 |
Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name "Sudarshan Specialty Chemsolve Private Limited" on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" on 17 December 2016. Thereafter, the Company converted into a Public Limited pursuant to a special resolution passed by shareholders at the EGM held on December 12, 2016 and consequently, name of the Company was changed to "Sudarshan Pharma Industries Limited" on January 5, 2017. The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. Driven by passion for building an integrated chemical and pharmaceutical company, backed by their more than two decades of individual experience, the Promoters have been the pillars of the Company`s growth since inception and have built a strong value system for the Company. With their enriching experience and progressive thinking, the company aims to continue to grow in the chemical and pharmaceutical industry in India and abroad. The Company outsources its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, the company provides order and get them manufactured from various suppliers in India and abroad regularly. Specialty chemicals and Intermediates having wide application in pharma, paint, food and adhesive Industry. It is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It also offer services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing the innovative products as per their needs. The Company carries about Ethical marketing of Pharmaceutical formulation & products in the Domestic and International market through distribution network and Sales force under its own brand. Presently, the Company has joined hands with regular suppliers having FDA and WHO approved plant along with their own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for their own brands. Apart from these, the Company has launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and has established goodwill for quality products and have regular clients for the same. Further, it supplies generic pharmaceutical formulation as Make to order for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports. The Company operate both in domestic and international markets. Presently, it is supplying Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets. It has entered into MOU / Agreements with Storage Houses / Warehouses facility providers at Bhiwandi Thane, Maharashtra, Wada Palghar, Maharashtra and Baddi, Himachal Pradesh for using their premises for the stock keeping of the products. The Company has also entered into Lease Agreement with Group Company, Sudarshan Chempharm LLP for using its premises and land to set up proposed Manufacturing and Storage / Warehouse Facility at Wada, in Maharashtra. In domestic pharmaceuticals markets, currently, the Company has good presence and is servicing through a Supply Chain Network of Consignee Agents with products range. It also provide onsite support & assistance to clients using their Drug Intermediates and Specialty Chemicals.
301 3rd Floor Aura Biplex, SV Road Borivali(West), Mumbai, Maharashtra, 400092
Tel | : | 91-22-42221111 |
: | compliance.spil:gmail.com | |
Website | : | http://www.sudarshanpharma.com |
KFin Techologies Ltd
AGM Date (Month) | : | Sep |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1600 |
BSE Code | : | 543828 |
NSE Code | : | |
Book Closure Date (Month) | : | Aug/Sep |
BSE Group | : | M |
ISIN | : | INE00TV01015 |
You can buy Sudarshan Pharma Industries Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Sudarshan Pharma Industries Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 16, 2024 04:01 PM the closing price of Sudarshan Pharma Industries Ltd was Rs.187.00.
The latest PE ratio of Sudarshan Pharma Industries Ltd as of Aug 16, 2024 04:01 PM is 39.29
The latest PB ratio of Sudarshan Pharma Industries Ltd as of Aug 16, 2024 04:01 PM is 0.25
The 52-week high of Sudarshan Pharma Industries Ltd share price is Rs. 198.20 while the 52-week low is Rs. 58.20
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Aug 16, 2024 04:01 PM, the market cap of Sudarshan Pharma Industries Ltd stood at Rs. 450.03 Cr.